Introduction Biologic and small-molecule therapies have revolutionised the treatment of moderate-to-severe inflammatory bowel disease (IBD). A significant proportion of patients experience early or delayed treatment failure. Patients with IBD with greater visceral obesity are less likely to respond to biologics. http://www.markbroyard.com/hot-sale-nutribiotic-grapefruit-citrus-seed-extract-traveler-s-friend-30ml-for-sale-limited-super/